Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-171789
Filing Date
2012-04-20
Accepted
2012-04-20 07:14:09
Documents
4
Period of Report
2012-05-24
Effectiveness Date
2012-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE & PROXY STATEMENT d294762ddef14a.htm DEF 14A 449136
2 GRAPHIC g294762g25o33.jpg GRAPHIC 8319
3 GRAPHIC g294762g41l36.jpg GRAPHIC 10032
4 GRAPHIC g294762g82v10.jpg GRAPHIC 7932
  Complete submission text file 0001193125-12-171789.txt   486927
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31791 | Film No.: 12769535
SIC: 2834 Pharmaceutical Preparations